Prospective Evaluation of 18F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRI

S Gaur, E Mena, SA Harmon… - American Journal of …, 2020 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to assess the utility of PET with (2 S)-2-[[(1 S)-1-
carboxy-5-[(6-(18F) fluoranylpyridine-3-carbonyl) amino] pentyl] carbamoylamino] …

18F-DCFBC prostate-specific membrane antigen–targeted PET/CT imaging in localized prostate Cancer: correlation with multiparametric MRI and histopathology

B Turkbey, E Mena, L Lindenberg, S Adler… - Clinical nuclear …, 2017 - journals.lww.com
Purpose To assess the ability of (N-[N-[(S)-1, 3-dicarboxypropyl] carbamoyl]-4-18 F-
fluorobenzyl-L-cysteine)(18 F-DCFBC), a prostate-specific membrane antigen–targeted PET …

18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer

SP Rowe, KL Gage, SF Faraj, KJ Macura… - Journal of Nuclear …, 2015 - Soc Nuclear Med
We previously demonstrated the ability to detect metastatic prostate cancer using N-[N-[(S)-
1, 3-dicarboxypropyl] carbamoyl]-4-18F-fluorobenzyl-l-cysteine (18F-DCFBC), a low …

Detection of clinically significant prostate cancer with 18F-DCFPyL PET/multiparametric MR

U Metser, C Ortega, N Perlis, E Lechtman… - European Journal of …, 2021 - Springer
Purpose To assess whether 18 F-DCFPyL PET/multiparametric (mp) MR contributes to the
diagnosis of clinically significant (cs) prostate cancer (PCa) compared to mpMR in patients …

A prospective phase II/III multicenter study of PSMA-targeted 18F-DCFPyL PET/CT imaging in patients with prostate cancer (OSPREY): A sub-analysis of regional and …

F Pouliot, P Carroll, S Probst, KJ Pienta, SP Rowe… - 2020 - ascopubs.org
9 Background: Current imaging modalities are suboptimal for the initial staging of men at risk
of harboring occult metastatic prostate cancer (PCa). PSMA-based imaging is considered …

Simultaneous 68Ga-PSMA HBED-CC PET/MRI improves the localization of primary prostate cancer

M Eiber, G Weirich, K Holzapfel, M Souvatzoglou… - European urology, 2016 - Elsevier
Background Ligands of the prostate-specific membrane antigen (PSMA) show promising
results in positron emission tomography (PET) imaging of prostate cancer (PCa). Objective …

Combination of 68Ga-PSMA PET/CT and multiparametric MRI improves the detection of clinically significant prostate cancer: a lesion-by-lesion analysis

M Chen, Q Zhang, C Zhang, X Zhao… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Our purpose was to explore whether 68Ga-PSMA PET/CT alone (PET/CT) or in combination
with multiparametric MRI (PET/MRI) can improve the detection of clinically significant …

Evaluating the value of 18F-PSMA-1007 PET/CT in the detection and identification of prostate cancer using histopathology as the standard

L Luo, A Zheng, R Chang, Y Li, J Gao, Z Wang, X Duan - Cancer Imaging, 2023 - Springer
Background Prostate-specific membrane antigen (PSMA) PET/CT is a highly regarded
radionuclide imaging modality for prostate cancer (PCa). This study aimed to evaluate the …

[HTML][HTML] Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer

TN Kwan, S Spremo, AYM Teh, D McHarg… - Prostate …, 2021 - Elsevier
Background We aimed to evaluate the utility of prostate-specific membrane antigen (PSMA)
PET/CT for the detection of local disease within the prostate. Methods This is a retrospective …

18F-DCFPyL PET/CT for primary staging in 160 high-risk prostate cancer patients; metastasis detection rate, influence on clinical management and preliminary …

M Wondergem, FM Van Der Zant, WAM Broos… - European Journal of …, 2021 - Springer
Purpose Prostate-specific membrane antigen (PSMA) PET/CT shows better diagnostic
performance for detection of lymph node and bone metastases as compared to conventional …